Open access
Open access
Powered by Google Translator Translator

Phase 1-2 study | Adagrasib with or without Cetuximab in colorectal cancer with mutated KRAS G12C

9 Jan, 2023 | 14:04h | UTC

Adagrasib with or without Cetuximab in Colorectal Cancer with Mutated KRAS G12C – New England Journal of Medicine (link to abstract – $ for full-text)

News Release: Advanced Colorectal Cancer Treatment Targets KRAS Gene With Drug Combo – Memorial Sloan Kettering Cancer Center

 

Commentary on Twitter

 


Stay Updated in Your Specialty

Telegram Channels
Free

WhatsApp alerts 10-day free trial

No spam, just news.